Hematopoietic Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationTransplantation ConditioningTransplantation, HomologousHematopoietic Stem CellsPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsStem Cell TransplantationGraft vs Host DiseaseMultiple MyelomaTreatment OutcomeCombined Modality TherapyMelphalanStem CellsBone MarrowDisease-Free SurvivalRetrospective StudiesBone Marrow CellsWhole-Body IrradiationLymphoma, Non-HodgkinGraft SurvivalSurvival RateCyclophosphamideTransplantation ChimeraMyeloablative AgonistsTissue DonorsRecurrenceRemission InductionAntigens, CD34LeukemiaBusulfanHematopoietic Stem Cell MobilizationImmunosuppressive AgentsHistocompatibility TestingHematopoiesisLiver TransplantationSalvage TherapyHistocompatibilitySurvival AnalysisAntineoplastic Combined Chemotherapy ProtocolsAnemia, AplasticCell DifferentiationCord Blood Stem Cell TransplantationTime FactorsMice, Inbred C57BLLeukemia, Myeloid, AcuteTransplantation, IsogeneicGraft vs Leukemia EffectMesenchymal Stem Cell TransplantationHepatic Veno-Occlusive DiseasePrognosisKidney TransplantationEmbryonic Stem CellsAntineoplastic AgentsBone and BonesChimerismAdult Stem CellsHematologic DiseasesFlow CytometryHLA AntigensTransplantation ImmunologyMyelodysplastic SyndromesCell LineageLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow PurgingColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaStem Cell NicheCell TransplantationSevere Combined ImmunodeficiencyGraft vs Tumor EffectGraft RejectionLymphocyte TransfusionCell ProliferationCells, CulturedT-LymphocytesLymphocyte DepletionFollow-Up StudiesAcute DiseaseGranulocyte Colony-Stimulating FactorImmunosuppressionLeukemia, MyeloidBone Marrow DiseasesMesenchymal Stromal CellsRadiation ChimeraPluripotent Stem CellsCell SeparationCytomegalovirus InfectionsSiblingsHeart TransplantationVidarabineAntilymphocyte SerumStem Cell FactorMultipotent Stem CellsUnrelated DonorsFetal BloodLung TransplantationOrgan TransplantationCytarabine